Related Experiment Videos
Molecular modeling of beta-cyclodextrin complexes with nootropic drugs
M E Amato1, F Djedaïni, G C Pappalardo
1Dipartimento di Scienze Chimiche, Università di Catania, Italy.
Journal of Pharmaceutical Sciences
|December 1, 1992
Summary
Molecular modeling revealed how beta-cyclodextrin (beta-CD) forms inclusion complexes with chiral antiamnesic drugs. The drug
Area of Science:
- Supramolecular Chemistry
- Computational Chemistry
- Medicinal Chemistry
Background:
- Beta-cyclodextrin (beta-CD) is a cyclic oligosaccharide known for its ability to form inclusion complexes.
- Chiral drugs require precise structural understanding for effective therapeutic development.
- Antiamnesic drugs are investigated for their potential to treat memory-related disorders.
Purpose of the Study:
- To investigate the geometry and structural features of beta-cyclodextrin inclusion complexes with specific chiral antiamnesic drugs.
- To elucidate the binding interactions and chiral discrimination mechanisms between beta-CD and the drug molecules.
- To model the conformational changes of beta-CD upon complex formation.
Main Methods:
- Molecular modeling using the MacroModel interactive computer program.
- Docking procedures to determine the most stable inclusion complex structures.
- Analysis of binding energies and hydrogen-bonded interactions.
- Separate modeling of R and S enantiomers to study chiral discrimination.
Main Results:
- The aromatic ring of the guest drugs was found to be positioned inside the beta-CD cavity, with the pyrrolidinone ring extending outwards.
- Binding energies were primarily attributed to hydrogen bonds involving the guest's carbonyl group (C=O).
- Selective interactions leading to chiral discrimination between drug enantiomers were observed.
- Beta-cyclodextrin adopted an elliptical shape upon complex formation, deviating from its isolated, nearly round structure.
Conclusions:
- Molecular modeling provides valuable insights into the structural basis of beta-cyclodextrin inclusion complexation with chiral drugs.
- The study highlights the role of hydrogen bonding and steric interactions in drug-guest complex stability and chiral recognition.
- The findings support the potential of beta-CD as a host molecule for chiral drug delivery and formulation.
- Computational results showed good agreement with experimental proton nuclear magnetic resonance (1H NMR) data.